Texas Instruments Incorporated (NASDAQ:TXN) was more active in the last trading session as around 4.31 million shares exchanged hands on Wall Street, representing an increase from its normal capacity of 4.13 million shares. A -0.14% change after the initial price of $98.55, sent the closing price to $98.4. Texas Instruments Incorporated has a consensus outperform rating from 32 Wall Street analysts, and the number of shares currently sold short amount to at least 1.19% of shares outstanding. The stock spiked 7.45% last month and is up 34.85 this year. Wall Street is only getting more bullish on the stock, with 14 of analysts who cover TXN having a buy-equivalent rating. Analysts have placed a $99.2 price target on Texas Instruments Incorporated, suggesting a 0.81% gain from recent close. It’s currently trading about -0.27% below its 52-week high. Texas Instruments Incorporated (TXN) surprised the stock market in its last reported earnings when it earned $1.26 a piece versus the consensus-estimated $1.12. Its revenue totaled $3.91 billion up 5.96% from the previous quarter.  This stock (TXN) is ahead of its 52-week low with 45.56%. Its last month’s stock price volatility remained 1.28% which for the week stands at 1.26%. The share price has moved forward from its 20 days moving average, trading at a distance of 3.22% and stays 9.83% away from its 50 days moving average. Over the last five days, shares have managed 1.77% gains and now is up 19.69% since hitting its 200-day moving average of $83.79. Texas Instruments Incorporated (TXN) has made its way to a 12-month gain of 42.59%. Turning to Pfizer Inc. (NYSE:PFE), its shares were trading at $35.36 a gain of $0.04, on the trading floor. The stock, after opening at $35.3, touched a high of $35.42 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.5. Pfizer Inc. has 4 buy ratings, 9 holds and 1 sells even after the stock tumbled -3.86% from its high of $36.78 to a $210.04 billion market value through last close. The company’s consensus rating on Reuter’s scale remained unchanged from 2.36 to 2.36 during a month. Analysts set a 12-month price target of $38.35 a share. The target implies a 8.46% spike from where the shares are currently trading. Also, the current price highlights a discount of 52.71% to analysts’ high consensus price target. The counter witnessed a trading volume of 9.58 million shares versus an average volume of 16.33 million shares during last trading session. Its last month’s stock price volatility remained 1.26% which for the week approaches 1.38%. The lowest price the stock reached in the last trading day was $35.24 and compares with the $29.96 52-week low. The stock recovered 18.02% since its low point and has performed 8.87% year-to-date.